France
Medesis Pharma is a pharmaceutical company based in France that has been in operation since 1991. The company's mission is encapsulated in its slogan, "A technology to deliver drugs to all cells from oral administration." Medesis Pharma has developed a groundbreaking technology, Aonys®, which represents a radical shift in drug delivery methodology. This innovative approach not only focuses on enhancing a drug's absorption characteristics but also ensures that the drug reaches its target site in the most effective manner.
The Aonys® drug delivery technology leverages the body's natural cellular delivery mechanisms to enable efficient drug delivery, effectively bypassing the natural barriers that drugs typically encounter. Medesis Pharma is conducting extensive research to apply the Aonys® technology to advanced therapeutics, such as therapeutic peptides, antisense oligonucleotides, and heavy metal chelating agents, which currently lack suitable delivery solutions.
The company is actively involved in clinical development programs for two Aonys® formulated products designed to address metabolic anomalies linked to insulin resistance (pre-diabetes) and neurodegeneration in Huntington's disease. Medesis Pharma's innovative approach to drug delivery has the potential to significantly impact the efficacy and targeted delivery of various therapeutics, marking a noteworthy advancement in the pharmaceutical industry.
